the effect of topical tranexamic acid in compare with topical hydroquinone4% is used in women with melasma
Phase 1
- Conditions
- melasma.chloasma
- Registration Number
- IRCT2016040627220N2
- Lead Sponsor
- vice chancellor for research of Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
inclusion criteria:
1.female gender,2.suffering melasma
exclusion criteria:
1.lack of compliance to continue the treatment,2.developed side effect of the treatment.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method